Brian R. Mueller

2020

In 2020, Brian R. Mueller earned a total compensation of $5.8M as Executive Vice President and Chief Financial Officer at BioMarin Pharmaceutical, a 248% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$363,000
Option Awards$845,333
Salary$600,923
Stock Awards$4,009,685
Other$21,590
Total$5,840,531

Mueller received $4M in stock awards, accounting for 69% of the total pay in 2020.

Mueller also received $363K in non-equity incentive plan, $845.3K in option awards, $600.9K in salary and $21.6K in other compensation.

Rankings

In 2020, Brian R. Mueller's compensation ranked 1,818th out of 13,090 executives tracked by ExecPay. In other words, Mueller earned more than 86.1% of executives.

ClassificationRankingPercentile
All
1,818
out of 13,090
86th
Division
Manufacturing
701
out of 5,620
88th
Major group
Chemicals And Allied Products
253
out of 2,253
89th
Industry group
Drugs
212
out of 1,953
89th
Industry
Pharmaceutical Preparations
150
out of 1,458
90th

Pay ratio

Brian R. Mueller's Pay$5,840,531
Median Employee's Pay$181,141
Pay Ratio

32

to 1

In 2020, the annual total compensation of Brian R. Mueller was $5,840,531.

The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.

The ratio of Brian R. Mueller's pay to the pay of median employee was therefore 32 to one.

Source: SEC filing on April 13, 2021.

Mueller's colleagues

We found six more compensation records of executives who worked with Brian R. Mueller at BioMarin Pharmaceutical in 2020.

2020

Jean-Jacques Bienaim

BioMarin Pharmaceutical

Chief Executive Officer

2020

Henry Fuchs

BioMarin Pharmaceutical

President, Worldwide R&D

2020

C Guyer

BioMarin Pharmaceutical

Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations

2020

Robert Baffi

BioMarin Pharmaceutical

Former President of Global Manufacturing and Technical Operations

2020

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

2020

Daniel Spiegelman

BioMarin Pharmaceutical

Chief Financial Officer

News

You may also like